This promotes the fast and aggressive progression of NAFLD to NASH via altered lipid catabolism within the hepatocytes containing endoplasmic-reticulum membranes and lipid-vesicles membranes that present the PNPLA3 I148M variant [70]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.